Showing results (761-770 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|April 18, 2019
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years LaterPawel Robak, Tadeusz RobakDrugs in R&D|May 11, 2019
A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney TransplantationJanet Kim, Sam Wilson, Nasrullah A Undre, et al.Drugs in R&D|May 23, 2019
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UKKristina S Boye, Dara Stein, Louis S Matza, et al.Drugs in R&D|November 24, 1999
Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disordersJ Goddard, D J WebbDrugs in R&D|November 24, 1999
Promising new agents in the prevention of transplant rejectionC Ponticelli, A TarantinoDrugs in R&D|November 24, 1999
Clinical potential of emerging antiarrhythmic agentsA Capucci, D Aschieri, G Q Villani, et al.Drugs in R&D|May 23, 2000
Recent developments and emerging therapies for type 2 diabetes mellitusA J Evans, A J KrentzDrugs in R&D|February 28, 2019
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous InfusionMaja Vimpolsek, Marie Gottar-Guillier, Emmanuel RossyDrugs in R&D|October 16, 2010
Effects of leukotriene receptor antagonists on peripheral eosinophil counts and serum IgE levels in children with food allergyYoko Yamakawa, Yoshikazu Ohtsuka, Kiyotaka Ohtani, et al.Drugs in R&D|June 18, 2011
Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a long-term special surveyTomoko Iizuka, Yasuhiro Nishikawa, Yoshihiro Mori, et al.Pageof 90